Europe Grants Authorization for Pfizer-BioNTech Vaccine

The European Medicines Agency has recommended authorizing the Coronavirus vaccine for people aged 16 and older, CNBC reported.

The authorized vaccine is the one developed by Pfizer and BioNTech, with vaccinations in Europe expected to start within a week.

This comes less than two weeks after the vaccine was rolled out in the United States.

Subject to the approval of the European Commission, many European countries are set to begin vaccinations on December 27.

The President-elect of the United States, Joe Biden, received his first dose of the vaccine earlier today.